SAB Biotherapeutics, Inc. (SABSW)
USD 0.03
(9.54%)
USD 0.03
(9.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.23 Million | 23.9 Million | 60.87 Million | 55.23 Million | 3.44 Million |
| Cost of Revenue | 3.74 Million | 3.29 Million | 1.65 Million | - | - |
| Gross Profit | -1.5 Million | 20.61 Million | 59.22 Million | 55.23 Million | 3.44 Million |
| Operating Expenses | 40.31 Million | 28.91 Million | 13.39 Million | 34.68 Million | 12.11 Million |
| Selling, General and Administrative Expenses | 20.05 Million | 16.38 Million | 17.08 Million | 6.77 Million | 4.09 Million |
| Research and Development Expenses | 16.51 Million | 36.43 Million | 57.18 Million | 27.9 Million | 8.01 Million |
| Other Expenses | - | -23.9 Million | -60.87 Million | 3996.00 | 2594.00 |
| Cost and Expenses | 40.31 Million | 28.91 Million | 13.39 Million | 34.68 Million | 12.11 Million |
| Operating Income | -38.07 Million | -28.91 Million | -13.39 Million | 20.55 Million | -8.67 Million |
| Interest Expense | 315.28 Thousand | 301.58 Thousand | 294.45 Thousand | 469.15 Thousand | 428.47 Thousand |
| Income Tax Expense | - | 25.62 Thousand | 299.94 Thousand | 473.14 Thousand | 431.07 Thousand |
| Earnings before Tax | -42.19 Million | -18.71 Million | -17.14 Million | 20.11 Million | -8.98 Million |
| Net Income | -42.19 Million | -18.74 Million | -17.44 Million | 20.11 Million | -9.41 Million |
| Earnings Per Share Basic | -7.64 | -4.31 | -6.38 | 7.92 | -0.22 |
| Earnings Per Share Diluted | -7.64 | -4.31 | -6.38 | 7.45 | -0.22 |
| Weighted Average Shares Outstanding | 5.52 Million | 4.35 Million | 2.73 Million | 2.53 Million | 43.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.52 Million | 4.35 Million | 2.73 Million | 2.7 Million | 43.47 Million |
| Gross Margin | -0.67 | 0.86 | 0.97 | 1.00 | 1.00 |
| EBIT Margin | -17.03 | -1.14 | -0.19 | 0.38 | -2.39 |
| Profit Margin | -18.85 | -0.78 | -0.29 | 0.36 | -2.74 |
| EBITDA | -38.13 Million | -15.12 Million | -15.19 Million | 21.13 Million | -8.23 Million |
| Earnings Before Tax Margin | -17.01 | -1.21 | -0.22 | 0.37 | -2.52 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 263.13 Thousand | 944.57 Thousand | 305.01 Thousand | 2.23 Million | 1.26 Million | 85.51 Thousand |
| Cost of Revenue | 1.02 Million | 1.98 Million | 944.4 Thousand | 3.74 Million | 985.44 Thousand | 892.26 Thousand |
| Gross Profit | -758.86 Thousand | -1.04 Million | -639.39 Thousand | -1.5 Million | 281.91 Thousand | -806.74 Thousand |
| Operating Expenses | 9.44 Million | 10.35 Million | 18.23 Million | 36.56 Million | 5.32 Million | 6.47 Million |
| Selling, General and Administrative Expenses | 2.64 Million | 2.22 Million | 13.93 Million | - | 2.57 Million | 2.9 Million |
| Research and Development Expenses | 6.8 Million | 8.12 Million | 4.29 Million | - | 4.01 Million | 3.66 Million |
| Other Expenses | 367.83 Thousand | 475.13 Thousand | 337.9 Thousand | - | 97.18 Thousand | - |
| Cost and Expenses | 10.46 Million | 12.33 Million | 19.17 Million | 40.31 Million | 5.32 Million | 6.47 Million |
| Operating Income | -10.2 Million | -11.39 Million | -18.87 Million | -38.07 Million | -5.32 Million | -6.47 Million |
| Interest Expense | 93.11 Thousand | 76.37 Thousand | 77.87 Thousand | -315.28 Thousand | 69.7 Thousand | 75.32 Thousand |
| Income Tax Expense | - | -13.37 Million | -1.00 | -2.00 | 166.88 Thousand | 75.32 Thousand |
| Earnings before Tax | -7.33 Million | -5.02 Million | -22.85 Million | -42.19 Million | -5.1 Million | -6.88 Million |
| Net Income | -7.33 Million | -5.02 Million | -22.85 Million | -42.19 Million | -5.1 Million | -6.88 Million |
| Earnings Per Share Basic | -0.79 | -0.54 | -3.86 | - | -0.97 | -1.36 |
| Earnings Per Share Diluted | -0.79 | -0.54 | -3.86 | - | -0.97 | -1.36 |
| Weighted Average Shares Outstanding | 9.25 Million | 9.24 Million | 5.92 Million | 5.52 Million | 5.24 Million | 5.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.25 Million | 9.24 Million | 5.92 Million | 5.52 Million | 5.24 Million | 5.04 Million |
| Gross Margin | -2.88 | -1.10 | -2.10 | -0.67 | 0.22 | -9.43 |
| EBIT Margin | -34.89 | -9.96 | -58.78 | - | -3.33 | -64.97 |
| Profit Margin | -27.88 | -5.32 | -74.94 | -18.85 | -4.03 | -80.46 |
| EBITDA | -9.17 Million | -9.4 Million | -17.92 Million | - | -4.22 Million | -5.55 Million |
| Earnings Before Tax Margin | -38.77 | -12.06 | -61.88 | -17.01 | -4.20 | -75.73 |
SANCO
9519
U1DA
HCH
002424
RAJRATAN